Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

DOCIVYX

DOCETAXEL

Standard Dose
160MG/16ML (10MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview DOCIVYX is listed in Drugs@FDA under application 215813 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient DOCETAXEL Form and strength SOLUTION;INTRAVENOUS - 160MG/16ML (10MG/ML) Sponsor AVYXA HOLDINGS Submission history Latest submission status date: 2025-01-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOCIVYX is listed in Drugs@FDA under application 215813 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient DOCETAXEL Form and strength SOLUTION;INTRAVENOUS - 160MG/16ML (10MG/ML) Sponsor AVYXA HOLDINGS Submission history Latest submission status date: 2025-01-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.